Bei Naga Markets registrieren
Merck & Co., US58933Y1055

Merck & Co. stock pre-market at EUR 131.17: plus 0.78 percent

Published on 10/13/2026 at 07:51 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Merck & Co. stock is at EUR 131.17 pre-market at Lang & Schwarz on October 13, 2026. That is plus 0.78 percent versus the Xetra close of October 12, 2026.

  • Merck & Co. stock trades at EUR 131.17 pre-market.
  • The price is up 0.78 percent versus the October 12 Xetra close.
  • Cantor Fitzgerald reiterated a Neutral rating and set a USD 145.00 price target.
Photorealistic wide-angle view of a modern oncology research laboratory. A scientist in white lab coat examines cancer cell slides under a fluorescence microscope. Amber glass vials with pharmaceutical compounds line the stainless steel bench. Biosafety c
Merck US58933Y1055 Onkologie-Labor: Wissenschaftler am Mikroskop analysiert Krebszellen, mehrere Wirkstoff-Vials stehen auf der Werkbank, Illustration mit AI erstellt.

Merck & Co. stock is at EUR 131.17 at Lang & Schwarz at 7:48 a.m. CEST on October 13, 2026. The price is up 0.78 percent versus the Xetra close of October 12, 2026, at EUR 130.16.

Pre-market setup

The Lang & Schwarz bid is EUR 130.92 and the ask is EUR 131.42. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Merck & Co. stock.

What matters today

The next market reference date is October 13, 2026. A round-number level of EUR 135.00 is 2.92 percent above the current price. Cantor Fitzgerald reiterated a Neutral rating and a USD 145.00 price target on October 12, 2026, according to Investing.com.

Market context: Market report S&P 500.

More news and analysis on Merck & Co. stock

Disclaimer...

en | US58933Y1055 | MERCK & CO. | boerse | 70309572 | bgmi